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Background: As people diagnosed with HIV and receiving combination antiretroviral therapy are now living longer,
they are likely to acquire chronic conditions related to normal ageing and the effects of HIV and its treatment.
Comordidities for people with HIV have not previously been described from a representative population perspective.
Methods: We used linked health administrative data from Ontario, Canada. We applied a validated algorithm to
identify people with HIV among all residents aged 18 years or older between April 1, 1992 and March 31, 2009. We
randomly selected 5 Ontario adults who were not identified with HIV for each person with HIV for comparison.
Previously validated case definitions were used to identify persons with mental health disorders and any of the
following physical chronic diseases: diabetes, congestive heart failure, acute myocardial infarction, stroke, hypertension,
asthma, chronic obstructive lung disease, peripheral vascular disease and end-stage renal failure. We examined
multimorbidity prevalence as the presence of at least two physical chronic conditions, or as combined physical-mental
health multimorbidity. Direct age-sex standardized rates were calculated for both cohorts for comparison.
Results: 34.4% (95% confidence interval (CI) 33.6% to 35.2%) of people with HIV had at least one other physical
condition. Prevalence was especially high for mental health conditions (38.6%), hypertension (14.9%) and asthma
(12.7%). After accounting for age and sex differences, people with HIV had significantly higher prevalence of all chronic
conditions except myocardial infarction and hypertension, as well as substantially higher multimorbidity (prevalence
ratio 1.30, 95% CI 1.18 to 1.44) and combined physical-mental health multimorbidity (1.79, 95% CI 1.65 to 1.94).
Prevalence of multimorbidity among people with HIV increased with age. The difference in prevalence of
multimorbidity between the two cohorts was more pronounced among women.
Conclusion: People living with HIV in Ontario, especially women, had higher prevalence of comorbidity and
multimorbidity than the general population. Quantifying this morbidity at the population level can help inform
healthcare delivery requirements for this complex population.
Keywords: Human immunodeficiency syndrome, Primary health care, Chronic disease, Comorbidity, Multimorbidity* Correspondence: ckendall@uottawa.ca
1C.T. Lamont Primary Health Care Research Centre, Bruyère Research Institute,
43 Bruyère St., Annex E., Ottawa, ON K1N 5C8, Canada
2Department of Family Medicine, University of Ottawa, 43 Bruyère St., Floor
3JB, Ottawa, ON K1N 5C8, Canada
Full list of author information is available at the end of the article
© 2014 Kendall et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
Kendall et al. BMC Public Health 2014, 14:161 Page 2 of 9
http://www.biomedcentral.com/1471-2458/14/161Background
The accumulation of chronic conditions over the lifespan
is a significant and rising burden on individuals and
healthcare systems. In Canada, 33% of community dwell-
ing individuals report having at least one of 7 common
chronic conditions [1]. There is strong evidence that the
management of chronic diseases is most effectively and
economically provided in well-supported primary care
settings [2,3]. The community-based management of these
chronic conditions consumes substantial healthcare re-
sources [4], and the bulk of this management occurs in
primary care [5,6].
As people with Human immunodeficiency syndrome
(HIV) on combination antiretroviral therapy (ART) are
now living longer, they are likely to acquire additional
chronic conditions related to normal aging as well as
from the effects of HIV and its treatment [7,8]. While
the literature regarding what factors contribute to the
prevalence of specific conditions is evolving, it is clear
that multimorbidity, the presence of several of these
conditions, is increasingly the norm for people with HIV
[9]. Early in the era of HIV, it was considered a deadly,
acute condition, requiring a specialist focus on care
[10-12]. However, with ART HIV becomes a chronic
condition, and a generalist perspective may now have a
more major role as comorbidities increase [13-17]. In
order to determine the best way to integrate primary
and specialist care [18], we require a full understanding
of the complex health needs of this population.
The specific objectives of this study are to describe the
prevalence of comorbidities and their multimorbidity for
people living with HIV and to compare this prevalence to
an age and sex adjusted general population. In Ontario,
Canada, administrative data for over 13 million multieth-
nic residents is routinely collected at the time of care in a
single-payer health system. These data can be used to
measure the prevalence of chronic disease [19]. To our
knowledge, this is the first study to use a population-based
approach to measure the types and numbers of chronic
diseases associated with HIV. As a result, this study will
inform the complex healthcare needs of this population.
Methods
Study design
We conducted a retrospective observational study to
examine the demographic and clinical characteristics
of people living with HIV in Ontario compared with
those in the general Ontario population. We analyzed
the administrative databases held at the Institute for
Clinical Evaluative Sciences (ICES) from the province of
Ontario, Canada comprising data on almost 13 million
individuals (2008). These data are made available to
accredited researchers through a data sharing agreement
with the Ontario Ministry of Health and Long-TermCare and are individually linked using an anonymous
identification number in accordance with the provincial
Personal Health Information Protection Act. The study
was approved by the Ottawa Hospital Research Ethics
Board and the Sunnybrook Health Sciences Centre Re-
search Ethics Board.
Study population
We identified eligible individuals from the Registered
Persons Database (RPDB), an electronic registry of all
Ontarians eligible for health coverage that captures patient
demographic information, including age, sex, postal code
and mortality data (see flow diagram Figure 1). We used
data from the Ontario Health Insurance Plan (OHIP)
billing claims system, which records claims for about
95% of physician services conducted in the province, to
obtain an HIV cohort. We applied a previously validated
algorithm to people 18 years of age and older and living in
Ontario between April 1, 1992 and April 1, 2009 [20].
Briefly, this algorithm requires 3 physician claims (Inter-
national Classification of Diseases, Ninth Revision (ICD-9)
code for HIV infection (042, 043, 044)) over a 3-year
period and has a sensitivity and specificity of 96.2% (95%
CI 95.2% - 97.9%) and 99.6% (95% CI 99.1% - 99.8%),
respectively for identifying people living with HIV and
receiving HIV care. As a comparison, a cohort of indi-
viduals 18 years or older, living in Ontario on April 1,
2009, and not in the HIV cohort was created using a
computerized random number generator in a 5:1 ratio
to the HIV cohort. For both cohorts, individuals without a
valid health card, age or sex value and those without valid
postal codes were excluded.
Variables
All variables for patients in the HIV and Ontario cohorts
were captured using identical methods. Age, sex and
postal code on April 1, 2009 were obtained from the
RPDB. To broadly describe the populations, we used
postal codes at the neighborhood level linked to 2006
Statistics Canada census data to assign income quin-
tiles, marginalization quintiles and rurality scores. We
used Matheson’s Canadian Marginalization Index [21]
to assign marginalization quintiles for four components
of marginalization (1 lowest to 5 highest): dependency,
residential instability, material deprivation, and ethnic con-
centration and present these as a summary score. Rurality
was assigned categorically into major urban areas (score 0
to 9), non-major urban areas (10 to 44), and rural areas (45
or higher) according to the Rurality Index of Ontario [22].
Using OHIP billing claims data, the Canadian Institute
for Health Information (CIHI) Discharge Abstract Data-
base, which supplies information on acute care hospi-
talizations and the CIHI National Ambulatory Care
Reporting System, which captures information on visits to
Figure 1 Flow diagram for study cohorts.
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validated algorithms in both cohorts to identify the status
(i.e. presence or absence) of the following physical comor-
bidities on April 1, 2009: diabetes, congestive heart failure,
acute myocardial infarction, hypertension, asthma, chronic
obstructive lung disease, stroke, end stage renal disease
and peripheral vascular disease [19,23-26]. People with
mental health conditions between April 1, 2007 and April
1, 2009 were broadly captured using an algorithm previ-
ously validated to identify people receiving mental health
services in the primary care setting [27].
Disease count was used to measure the prevalence of
multimorbidity [28]. Multimorbidity was defined as the
presence of two or more listed physical chronic condi-
tions, and physical-mental health comorbidity was de-
fined as a combination of mental health condition and
any physical chronic health condition. In patients in the
HIV cohort, this multimorbidity is in addition to HIV as
their index condition.
We used the Ontario Drug Benefits claims database to
identify individuals in the cohorts who were prescribed
drugs paid for by the public system which covers those
aged 65 and older and those receiving social assistance
(Ontario Works, Ontario Disability Support Program, or
the subsidized Trillium program).
Statistical analysis
We used descriptive statistics to describe the demographic
characteristics of the two cohorts. For our descriptiveanalyses, age was treated as both a continuous variable
and a categorical variable. Sex, age group, income quin-
tiles, rurality categories and use of Ontario Drug Benefits
were described as categorical variables, and the marginal-
ization composite score as a continuous variable. These
characteristics were compared between the cohorts using
two-sample t-tests for continuous variables and chi-squared
tests for categorical variables. We calculated the prevalence
of individual physical and mental health comorbidities,
multimorbidity, and physical-mental health comorbid-
ity in the HIV cohort, together with 95% confidence
intervals (CI).
We used direct standardization to calculate age and
sex standardized prevalence rates for both populations.
The Canadian 1991 population was used as the reference
standard [29]. We present the comparative ratio of these
rates together with 95% confidence interval, calculated
using the formula provided by Breslow and Day [30].
We also compare the prevalence of comorbidity and
multimorbidity with age between the HIV and Ontario
cohorts for both men and women. All statistical analyses
were performed using SAS version 9.2 (SAS Institute,
Cary, North Carolina).
Results
Table 1 provides for descriptive purposes the demographic
characteristics of people in the HIV cohort compared
to the Ontario cohort. The sex and age distributions
differed substantially between the HIV and Ontario
Table 1 Demographic characteristics of HIV and Ontario cohorts (April 1, 2009)
HIV cohort Ontario cohort p-value
n = 14,005 n = 71410
Age (years) Mean (SD) 45.36 (10.77) 46.65 (17.79) <.001
Age group (n, %) 18-35 years 2,355 (16.8%) 21,600 (30.2%) <.001
36-50 years 7,798 (55.7%) 21,895 (30.7%)
51-65 years 3,283 (23.4%) 16,575 (23.2%)
>65 years 569 (4.1%) 11,340 (15.9%)
Sex (n, %) Male 11,270 (80.5%) 34,862 (48.8%) <.001
Income quintile (1 lowest, 5 highest) Missing 131 (0.9%) 302 (0.4%) <.001
1 4,441 (31.7%) 13,918 (19.5%)
2 2,875 (20.5%) 14,224 (19.9%)
3 2,280 (16.3%) 14,053 (19.7%)
4 2,085 (14.9%) 14,554 (20.4%)
5 2,193 (15.7%) 14,359 (20.1%)
Marginalization index Mean (SD) 3.35 (0.74) 2.97 (0.78) <.001
Rurality group Missing 41 (0.3%) 596 (0.8%)
Major urban 41 (0.3%) 596 (0.8%)
Non-major urban 12,563 (89.7%) 52,020 (72.8%) <.001
Rural 1,006 (7.2%) 13,341 (18.7%)
ODB claim Yes 395 (2.8%) 5,453 (7.6%)
8,789 (62.8%) 21,509 (30.1%) <.001
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(80.5% vs. 48.8%, p < 0.001) and less likely to be in the
youngest (18–35 years) or oldest (>65 years) age groups
(16.8% vs. 30.2% and 4.1% vs. 15.9% respectively, p < 0.001).
Overall, people with HIV were poorer (lowest income quin-
tile 31.7% vs 19.5%, p < 0.001), lived in more marginalized
neighborhoods (marginalization index 3.35 (SD 0.74) vs.
2.97 (SD 0.7), p < 0.001), were more likely to live in urban
settings (89.7% vs. 72.8%, p < 0.001) and were more likely to
have obtained provincial drug benefits than those in the
Ontario cohort (62.8% vs. 30.1%, p < 0.001).
The prevalence of individual comorbidities and of
multimorbidity among individuals in the HIV cohort are
presented in Table 2. More than one-third (38.6%, 95%
CI 37.8% to 39.4%) of people with HIV had a mental
health condition diagnosed within the previous 2 years.
One-third (34.4%, 95% CI 33.6% to 35.2%) had at least
one physical chronic condition in addition to their HIV.
Comorbidities with especially high prevalence included
hypertension (14.9%), asthma (12.7%), diabetes (8.3%) and
chronic obstructive pulmonary disease (7.9%). The preva-
lence of multimorbidity (at least two physical conditions)
was 10.8% (95% CI 10.3% to 11.3%), and of physical-mental
health comorbidity was 15.5% (95% CI 14.9% to 16.1%).
Table 3 presents the age and sex standardized preva-
lence rates for the two cohorts (standardized to the 1991
Canadian population), along with the prevalence rateratios and 95% confidence intervals. After accounting for
age and sex differences, people in the HIV cohort were
more likely to have at least one chronic condition than
those in the Ontario cohort (prevalence ratio 1.13, 95%
CI 1.07 to 1.20). People with HIV had significantly higher
prevalence of all chronic conditions except myocardial
infarction and hypertension, which were not significantly
different from the general population. Individuals with
HIV had substantially higher multimorbidity (prevalence
ratio 1.30, 95% CI 1.18 to 1.44) and physical-mental health
comorbidity (1.79, 95% CI 1.65 to 1.94) than the Ontario
population.
Figure 2 shows the prevalence of comorbidity and
multimorbidity, for men and women respectively, by age
group for the HIV and Ontario cohorts. Prevalence of
multimorbidity increased with age in all groups and was
higher for women than men. Men in the HIV cohort
only had higher prevalence of at least one chronic condi-
tion and multimorbidity than men in the Ontario cohort
in the younger age groups. In contrast, multimorbidity
prevalence among women with HIV was consistently
higher than among Ontario women in all age groups,
and this gap appeared to widen slightly with age.
Discussion
Our study quantifies the substantial comorbidity preva-
lence among people living with HIV in Ontario. Mental
Table 2 Comorbidities and multimorbidity prevalence of people living with HIV in Ontario (April 1, 2009)
Comorbidity Prevalence
N = 14,005 (n) (%) 95% CI
Mental health condition 5,401 38.6% (37.8% to 39.4%)
Physical conditions:
Myocardial infarction 174 1.2% (1.1% to 1.4%)
Congestive heart disease 233 1.7% (1.5% to 1.9%)
Chronic obstructive pulmonary disease 1,106 7.9% (7.5% to 8.3%)
End stage renal disease 223 1.6% (1.4% to 1.8%)
Peripheral vascular disease 72 0.5% (0.4% to 0.6%)
Asthma 1,780 12.7% (12.2% to 13.3%)
Diabetes 1,167 8.3% (7.9% to 8.8%)
Hypertension 2,093 14.9% (14.4% to 15.5%)
Stroke 173 1.2% (1.1% to 1.4%)
At least one physical condition 4820 34.4% (33.6% to 35.2%)
Physical-mental health multimorbidity 2,174 15.5% (14.9% to16.1%)
Multimorbidity (at least two physical conditions) 1,508 10.8% (10.3% to 11.3%)
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were more prevalent among people with HIV than among
the general population, as were multimorbidity and
physical-mental health comorbidity. In addition, as is
seen in the general population, our study confirms the
accumulation of multiple chronic conditions with age
for both men and women with HIV. Women had higher
multimorbidity than men across all groups, which is
consistent with the Canadian general population [1].Table 3 Comparison of comorbidities and multimorbidity pre





Mental health condition 5401 40.5
Physical conditions:
Acute myocardial infarction 174 1.19
Congestive heart failure 233 3.35
Chronic obstructive lung disease 1106 8.33
End stage renal disease 223 1.96





At least one physical condition 4820 38.7
Physical-mental health multimorbidity 2174 16.9
Multimorbidity (at least two physical conditions) 1508 14.4Furthermore, while men with HIV had slightly lower
comorbidity and multimorbidity than Ontario men in
most age groups, women with HIV had consistently
higher comorbidity and multimorbidity prevalence than
women without HIV.
To our knowledge, this is the first study to use a
population-based approach to measure the types and num-
bers of chronic diseases associated with HIV; most studies
have been conducted in clinical cohorts of people livingvalence between HIV and Ontario cohorts (standardized
Ontario cohort HIV:ON
N = 71,410
nce n Prevalence Prevalence ratio (95% CI)
(%)
5 15935 21.99 1.84 (1.75,1.94)
949 1.06 1.12 (0.78,1.60)
1428 1.49 2.26 (1.74,2.92)
4621 5.33 1.56 (1.39,1.76)
631 0.76 2.57 (1.92,3.44)
248 0.29 2.15 (1.35,3.40)
0 8448 12.13 1.31 (1.20,1.43)
6730 8.13 1.19 (1.06,1.33)
3 16886 20.29 0.95 (0.88,1.04)
891 1.01 1.53 (1.15,2.03)
2 26907 34.23 1.13 (1.07,1.20)
8 7443 9.49 1.79 (1.65,1.94)
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Figure 2 Morbidity prevalence by age group among men and women with HIV versus the Ontario general population.
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with HIV is clearly high, there have been inconsistencies
regarding which conditions are more or less common in
people with HIV. For instance, Butt et al. [31] found that
HIV was associated with a decreased risk of diabetes, but
that increasing age had a greater effect on diabetes rates in
those with HIV than in the general population. Crothers
et al. [32] found HIV to be an independent risk factor forCOPD even after adjusting for smoking status and other
risk factors. In their very large, almost exclusively male
study comparing HIV positive with non HIV positive
veterans, Goulet et al. [33] found that those with HIV
had lower risk of hypertension, diabetes, vascular disease
and psychiatric disorders, and higher rates of renal and
liver disease than their HIV negative cohort. In their study
of ART-experienced patients, Guaraldi et al. [8] found that
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http://www.biomedcentral.com/1471-2458/14/161those who were HIV positive had higher rates of diabetes,
bone fracture and renal failure, but no difference in
cardiovascular disease and hypertension. It is likely that
the prevalence of individual comorbidities is a result of
the complex interplay of aging, behavioral risk factors
such as smoking (known to be higher among those with
HIV), genetic risk factors, HIV severity, and ART history
[8,9,34-36].
This study offers the unique strength of presenting the
multimorbidity of people with HIV from a broad, multi-
ethnic population of men and women from a variety of
socioeconomic groups. Our findings are consistent with
the literature highlighting that multimorbidity is common
for people with HIV [7,8,33,34]. However, previously pub-
lished prevalences of multimorbidity vary depending on
the population base of the study, as clinical cohorts of
people with HIV are often limited to certain demographic
populations or at-risk groups. For example, our study
showed that women with HIV have excess multimorbidity,
which is consistent with Salter’s study of HIV positive in-
jection drug users, but not with Guaraldi’s study of poly-
pathology in ART-experienced people with HIV enrolled
in a metabolic clinic. As men have historically represented
a larger but decreasing proportion of people living with
HIV, it is possible that Ontario men who were infected
earlier in the epidemic were sicker and had higher mortal-
ity, resulting in a healthier cohort of older HIV-positive
men within our population. However, because our popula-
tion base isn’t limited by the definition of any high risk
cohort and presents the clinical experience of people
currently living with HIV our data is likely to be a
robust estimate of the prevalence of comorbidities in
the population.
In addition, previous studies have varied with respect
to definitions for multimorbidity, such as specific diseases
included, methods of clustering conditions, and numbers
of conditions required to meet multimorbidity criteria.
[5,37-40]. It is likely that broadening our comorbidity
measures would have resulted in higher prevalence of
multimorbidity [7,33]. Finally, in finding that almost 50%
of people with HIV who have at least one comorbidity also
have a mental health diagnosis, our study is the first to
our knowledge to quantify the relationship between these
conditions. Barnett et al. [37] found that those living in
the most deprived areas had the highest prevalence of
physical-mental health comorbidity at 11.0%, which is
lower than the prevalence found in our HIV population,
despite their higher deprivation compared to the Ontario
general population.
There are several limitations to our study. First, we did
not identify those who were unaware of their HIV status,
estimated to be 26% of prevalent infections in Canada
[41], or those not accessing health care. Furthermore,
there are some settings in Ontario, most notablycommunity health centres, that are not included in ad-
ministrative data and so HIV patients in these setting
where not included in the study. Community health cen-
tres are estimated to provide primary care for about 1%
of the Ontario population [42], thus our findings are
unlikely to be substantially affected by missing these
individuals. Second, we were initially concerned that
providers, especially those who have high-volume HIV
practices or those who receive incentives for providing
HIV care, would have preferentially identified HIV
diagnosis codes for services received over other codes
for chronic conditions. This potential bias would result
in under ascertainment of chronic conditions in the
HIV population compared to the general population. In
light of this ascertainment issue, we are confident in
our finding that, compared to the general Ontario
population, the prevalence of almost all chronic condi-
tions among those with HIV is higher.
Conclusion
This population-based study quantifies the substantially
higher comorbidity and multimorbidity prevalence among
people living with HIV relative to the general population,
and the high contribution of mental health diagnoses
to these conditions. This additional burden of disease
increasingly defines the care needs of this population
[43,44]. Strategies for chronic disease management, includ-
ing for people with HIV, must be expanded with a view to
multimorbidity [18,37,43,45,46]. Particular attention should
be paid to the complex care needs defined by the comor-
bidity burden on women with HIV. By contributing to
quantifying this increasing burden with age, our results
can inform policy direction around HIV health services
delivery. Future work will be directed at understanding
how these complex patients access the healthcare system,
and how providers are meeting the healthcare needs of
this population.
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